Last updated: 1 August 2024 at 3:45pm EST

Michael D. Witzeman CPA, MBA Net Worth




The estimated Net Worth of Michael D Witzeman is at least $16.3 Milión dollars as of 31 July 2024. Mr Witzeman owns over 7,948 units of Chemed stock worth over $6,244,525 and over the last 8 years he sold CHE stock worth over $9,064,114. In addition, he makes $991,144 as VP & Controller at Chemed.

Mr MBA CHE stock SEC Form 4 insiders trading

Mr has made over 28 trades of the Chemed stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 7,948 units of CHE stock worth $3,749,390 on 31 July 2024.

The largest trade he's ever made was exercising 8,000 units of Chemed stock on 4 November 2020 worth over $1,855,280. On average, Mr trades about 2,157 units every 66 days since 2017. As of 31 July 2024 he still owns at least 11,009 units of Chemed stock.

You can see the complete history of Mr Witzeman stock trades at the bottom of the page.





Mr. Michael D. Witzeman CPA, MBA biography

Michael D. Witzeman CPA, MBA is the VP & Controller at Chemed.

What is the salary of Mr MBA?

As the VP & Controller of Chemed, the total compensation of Mr MBA at Chemed is $991,144. There are 8 executives at Chemed getting paid more, with Kevin McNamara having the highest compensation of $10,019,800.



How old is Mr MBA?

Mr MBA is 50, he's been the VP & Controller of Chemed since . There are 16 older and 3 younger executives at Chemed. The oldest executive at Chemed Corp. is Walter Krebs, 86, who is the Independent Director.

What's Mr MBA's mailing address?

Michael's mailing address filed with the SEC is 2600 CHEMED CENTER, 255 EAST FIFTH STREET, CINCINNATI, OH, 45202.

Insiders trading at Chemed

Over the last 22 years, insiders at Chemed have traded over $138,634,486 worth of Chemed stock and bought 2,293 units worth $478,104 . The most active insiders traders include Kevin J Mcnamara, David Patrick Williams a Spencer S Lee. On average, Chemed executives and independent directors trade stock every 19 days with the average trade being worth of $4,438,497. The most recent stock trade was executed by Nicholas Michael Westfall on 9 September 2024, trading 1,713 units of CHE stock currently worth $975,297.



What does Chemed do?

chemed is a holding company. our wholly owned subsidiaries are vitas and roto-rooter services company. vitas is a healthcare company that specializes in hospice or end of life care for the terminally ill. roto-rooter is the nation's largest provider of plumbing and drain care services.



What does Chemed's logo look like?

Chemed Corp. logo

Complete history of Mr Witzeman stock trades at Chemed

Dátum
#
Spoločnosť
Človek
Trans.
Transakcia
Počet akcií Cena za akciu Celková cena Počet akcií po Zdroj
31 Jul 2024 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Využitie opcie 7,948 $471.74 $3,749,390
31 Jul 2024
11,009
7 May 2024 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Využitie opcie 1,100 $413.19 $454,509
7 May 2024
3,982
20 Mar 2024 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Predaj 2,650 $643.14 $1,704,321
20 Mar 2024
2,882
16 Feb 2024 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Využitie opcie 433 $586.49 $253,950
16 Feb 2024
3,417
8 Nov 2023 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Využitie opcie 3,300 $413.19 $1,363,527
8 Nov 2023
5,669
17 Feb 2023 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Využitie opcie 669 $515.12 $344,615
17 Feb 2023
2,569
10 Nov 2022 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Predaj 736 $498.47 $366,874
10 Nov 2022
1,900
3 Nov 2022 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Využitie opcie 6,900 $306.70 $2,116,230
3 Nov 2022
8,086
18 Feb 2022 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Využitie opcie 897 $459.77 $412,414
18 Feb 2022
2,752
19 Feb 2021 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Využitie opcie 1,082 $491.34 $531,630
19 Feb 2021
4,032
17 Dec 2020 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Predaj 2,500 $520.00 $1,300,000
17 Dec 2020
2,950
4 Nov 2020 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Využitie opcie 8,000 $231.91 $1,855,280
4 Nov 2020
12,001
3 Aug 2020 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Predaj 2,000 $500.00 $1,000,000
3 Aug 2020
4,001
21 Feb 2020 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Využitie opcie 1,111 $487.90 $542,057
21 Feb 2020
6,335
4 Dec 2019 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Predaj 2,500 $435.00 $1,087,500
4 Dec 2019
5,224
21 Nov 2019 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Využitie opcie 6,667 $135.85 $905,712
21 Nov 2019
9,667
16 Aug 2019 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Predaj 4,349 $432.50 $1,880,943
16 Aug 2019
3,000
12 Aug 2019 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Využitie opcie 8,000 $119.28 $954,240
12 Aug 2019
12,000
12 Mar 2019 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Predaj 735 $328.00 $241,080
12 Mar 2019
4,000
22 Feb 2019 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Využitie opcie 1,097 $322.40 $353,673
22 Feb 2019
5,097
24 Aug 2018 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Predaj 1,706 $322.00 $549,332
24 Aug 2018
4,000
30 Jul 2018 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Využitie opcie 3,551 $70.30 $249,635
30 Jul 2018
7,670
2 May 2018 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Predaj 1,000 $313.00 $313,000
2 May 2018
4,270
24 Apr 2018 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Využitie opcie 3,333 $135.85 $452,788
24 Apr 2018
7,347
16 Feb 2018 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Využitie opcie 972 $256.29 $249,114
16 Feb 2018
4,306
4 Dec 2017 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Predaj 1,000 $250.00 $250,000
4 Dec 2017
3,334
16 Nov 2017 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Predaj 1,579 $235.00 $371,065
16 Nov 2017
4,334
6 Nov 2017 Michael D Witzeman
Viceprezident a Finančný riaditeľ
Využitie opcie 4,000 $157.36 $629,440
6 Nov 2017
9,026


Chemed executives and stock owners

Chemed executives and other stock owners filed with the SEC include: